NASDAQ : GLUE
Monte Rosa Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 10.87 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 927.36M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Monte Rosa Therapeutics, Inc. (GLUE) reported revenue of 28.73M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 28.73M | 123.67M | 75.62M | |||
| Cost of Revenue | 162.36M | 133.70M | 112.86M | 103.37M | ||
| Gross Profit | -133.63M | -10.03M | -37.24M | -103.37M | ||
| Selling, General & Admin | 48.22M | 44.18M | 43.87M | 39.94M | 35.12M | 15.73M |
| Research & Development | 77.26M | 57.16M | ||||
| Operating Expenses | 48.22M | 44.18M | 43.87M | 39.94M | 112.38M | 72.88M |
| Operating Income | -181.85M | -54.21M | -81.11M | -143.31M | -112.38M | -72.88M |
| Interest & Investment Income | 17.94M | 12.94M | 10.57M | 9.33M | 3.76M | 46.00K |
| Currency Exchange Gain (Loss) | -62.00K | 1.48M | 416.00K | -930.00K | 10.00K | -162.00K |
| Other Non Operating Income (Expenses) | -960.00K | |||||
| EBT Excluding Unusual Items | -163.97M | -39.78M | -70.13M | -134.91M | -108.61M | -73.96M |
| Gain (Loss) on Sale of Investments | -131.00K | |||||
| Gain (Loss) on Sale of Assets | 59.00K | 24.00K | 109.00K | |||
| Pretax Income | -163.97M | -39.72M | -70.13M | -135.01M | -108.50M | -73.96M |
| Income Tax Expense | -2.86M | -1.10M | 2.57M | 338.00K | ||
| Net Income | -161.12M | -38.63M | -72.70M | -135.35M | -108.50M | -73.96M |
| Net Income to Common | -161.12M | -38.63M | -72.70M | -135.35M | -108.50M | -73.96M |
| Shares Outstanding (Basic) | 92.33M | 83.07M | 73.91M | 51.40M | 47.23M | 25.00M |
| Shares Outstanding (Diluted) | 92.33M | 83.07M | 73.91M | 51.40M | 47.23M | 25.00M |
| EPS (Basic) | -1.74 | -0.46 | -0.98 | -2.63 | -2.30 | -2.96 |
| EPS (Diluted) | -1.74 | -0.46 | -0.98 | -2.63 | -2.30 | -2.96 |
| Free Cash Flow | -32.08M | -27.50M | 38.01M | -62.84M | -105.38M | -69.09M |
| Free Cash Flow Per Share | -0.35 | -0.33 | 0.51 | -1.22 | -2.23 | -2.76 |
| Gross Margin | -8.11% | -49.25% | ||||
| Operating Margin | -633.04% | -43.83% | -107.26% | |||
| Profit Margin | -560.85% | -31.23% | -96.14% | |||
| Free Cash Flow Margin | -111.66% | -22.23% | 50.26% | |||
| EBITDA | -173.73M | -45.85M | -72.99M | -137.09M | -108.64M | -70.75M |
| EBITDA Margin | -37.08% | -96.52% | ||||
| D&A For EBITDA | 8.13M | 8.36M | 8.12M | 6.22M | 3.75M | 2.13M |
| EBIT | -181.85M | -54.21M | -81.11M | -143.31M | -112.38M | -72.88M |
| EBIT Margin | -43.83% | -107.26% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 90.10M | 129.88M | 224.25M | 128.10M | 54.91M | 346.07M |
| Short-Term Investments | 531.00M | 247.22M | 147.90M | 104.31M | 207.91M | |
| Cash & Short-Term Investments | 621.10M | 377.10M | 372.15M | 232.41M | 262.83M | 346.07M |
| Other Receivables | 4.92M | 11.60M | 173.00K | 505.00K | 7.66M | |
| Receivables | 4.92M | 11.60M | 173.00K | 505.00K | 7.66M | |
| Prepaid Expenses | 5.38M | 4.48M | 5.12M | 3.29M | 4.44M | 2.60M |
| Restricted Cash | 960.00K | |||||
| Total Current Assets | 631.41M | 393.19M | 377.44M | 236.21M | 275.89M | 348.67M |
| Property, Plant & Equipment | 53.99M | 50.37M | 56.31M | 62.61M | 61.91M | 12.32M |
| Other Long-Term Assets | 5.77M | 5.10M | 4.98M | 4.93M | 4.60M | 5.34M |
| Total Assets | 691.16M | 448.66M | 438.73M | 303.75M | 342.39M | 366.33M |
| Accounts Payable | 7.15M | 3.55M | 17.21M | 11.15M | 7.86M | 6.56M |
| Accrued Expenses | 23.96M | 25.12M | 15.43M | 12.93M | 9.56M | 9.24M |
| Current Portion of Leases | 4.63M | 4.40M | 3.71M | 3.16M | 3.13M | |
| Current Unearned Revenue | 22.10M | 29.57M | 117.23M | 17.68M | ||
| Other Current Liabilities | 1.81M | 1.58M | 3.35M | 1.67M | 5.02M | 840.00K |
| Total Current Liabilities | 59.66M | 64.21M | 156.95M | 46.59M | 25.57M | 16.64M |
| Long-Term Leases | 33.36M | 34.79M | 39.00M | 42.88M | 43.87M | |
| Long-Term Unearned Revenue | 105.62M | 111.33M | 16.15M | 32.32M | ||
| Pension & Post-Retirement Benefits | 5.24M | 5.26M | 3.70M | 2.71M | 1.53M | 2.18M |
| Total Liabilities | 203.88M | 215.60M | 215.80M | 124.50M | 70.98M | 18.81M |
| Common Stock | 9.00K | 7.00K | 6.00K | 5.00K | 5.00K | 5.00K |
| Additional Paid-In Capital | 1.06B | 714.09M | 664.87M | 547.86M | 503.70M | 471.57M |
| Retained Earnings | -565.11M | -477.21M | -438.59M | -365.89M | -230.54M | -122.03M |
| Comprehensive Income & Other | -5.17M | -3.83M | -3.36M | -2.72M | -1.75M | -2.02M |
| Total Common Equity | 487.28M | 233.06M | 222.94M | 179.25M | 271.41M | 347.51M |
| Shareholders' Equity | 487.28M | 233.06M | 222.94M | 179.25M | 271.41M | 347.51M |
| Total Liabilities & Equity | 691.16M | 448.66M | 438.73M | 303.75M | 342.39M | 366.33M |
| Total Debt | 37.99M | 39.19M | 42.72M | 46.04M | 47.00M | |
| Net Cash (Debt) | 583.12M | 337.91M | 329.43M | 186.37M | 215.82M | 346.07M |
| Net Cash Per Share | 6.32 | 4.07 | 4.46 | 3.63 | 4.57 | 13.84 |
| Filing Date Shares Outstanding | 85.31M | 80.02M | 61.51M | 50.14M | 49.24M | 46.37M |
| Total Common Shares Outstanding | 85.23M | 65.54M | 61.51M | 50.14M | 49.32M | 46.54M |
| Working Capital | 571.75M | 328.97M | 220.49M | 189.62M | 250.32M | 332.03M |
| Book Value Per Share | 5.72 | 3.56 | 3.62 | 3.57 | 5.50 | 7.47 |
| Tangible Book Value | 487.28M | 233.06M | 222.94M | 179.25M | 271.41M | 347.51M |
| Tangible Book Value Per Share | 5.72 | 3.56 | 3.62 | 3.57 | 5.50 | 7.47 |
| Machinery | 36.09M | 29.81M | 27.40M | 24.23M | 18.65M | 13.06M |
| Construction In Progress | 411.00K | 118.00K | 64.00K | 924.00K | 12.01M | 852.00K |
| Leasehold Improvements | 24.98M | 23.67M | 22.39M | 20.89M | 2.66M | 1.12M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -161.12M | -38.63M | -72.70M | -135.35M | -108.50M | -73.96M |
| Depreciation & Amortization | 10.79M | 10.86M | 10.22M | 8.32M | 3.75M | 2.13M |
| Loss (Gain) From Sale of Assets | -59.00K | -24.00K | -109.00K | 17.00K | ||
| Loss (Gain) From Sale of Investments | -2.34M | -2.15M | -2.95M | -3.78M | -1.95M | |
| Stock-Based Compensation | 20.59M | 18.86M | 18.13M | 16.67M | 11.66M | 5.20M |
| Other Operating Activities | -2.66M | -2.50M | -2.10M | -2.10M | 4.81M | 960.00K |
| Change in Accounts Receivable | -2.55M | -4.43M | 332.00K | 1.90M | -187.00K | |
| Change in Accounts Payable | 1.15M | -13.71M | 6.25M | 5.76M | -744.00K | -706.00K |
| Change in Unearned Revenue | 101.26M | 7.52M | 83.38M | 50.00M | ||
| Change in Other Net Operating Assets | 10.81M | 1.42M | 1.44M | 14.81M | -1.20M | 6.99M |
| Operating Cash Flow | -24.07M | -22.80M | 42.00M | -43.80M | -92.47M | -59.36M |
| Capital Expenditures | -8.01M | -4.70M | -3.99M | -19.04M | -12.91M | -9.73M |
| Sale of Property, Plant & Equipment | 62.00K | 109.00K | 79.00K | |||
| Investment in Securities | -308.78M | -97.13M | -40.46M | 107.78M | -206.42M | |
| Investing Cash Flow | -316.79M | -101.83M | -44.45M | 88.80M | -219.22M | -9.65M |
| Issuance of Common Stock | 383.06M | 30.71M | 52.53M | 2.61M | 21.45M | 255.79M |
| Other Financing Activities | -21.54M | -357.00K | 46.36M | 24.88M | -984.00K | -21.23M |
| Financing Cash Flow | 361.52M | 30.35M | 98.89M | 27.49M | 20.47M | 377.56M |
| Net Cash Flow | 20.66M | -94.28M | 96.44M | 72.49M | -291.22M | 308.55M |
| Free Cash Flow | -32.08M | -27.50M | 38.01M | -62.84M | -105.38M | -69.09M |
| Free Cash Flow Margin | -111.66% | -22.23% | 50.26% | |||
| Free Cash Flow Per Share | -0.35 | -0.33 | 0.51 | -1.22 | -2.23 | -2.76 |
| Levered Free Cash Flow | -74.45M | -113.07M | 81.97M | -53.37M | -72.40M | -61.29M |
| Unlevered Free Cash Flow | -74.45M | -113.07M | 81.97M | -53.37M | -72.40M | -61.29M |
| Change in Working Capital | 110.67M | -9.19M | 91.40M | 72.47M | -2.13M | 6.29M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 906.88M | 1.02B | 426.37M | 282.85M | 368.32M | 949.65M |
| Enterprise Value | 323.76M | 669.96M | 227.88M | 150.77M | 141.83M | 582.62M |
| Last Close Price | 10.76 | 15.68 | 6.94 | 5.65 | 7.61 | 20.42 |
| PS Ratio | 31.57 | 8.26 | 5.64 | |||
| PB Ratio | 1.88 | 4.38 | 1.91 | 1.58 | 1.36 | 2.73 |
| P/TBV Ratio | 1.86 | 4.38 | 1.91 | 1.58 | 1.36 | 2.73 |
| P/FCF Ratio | 11.22 | |||||
| P/OCF Ratio | 10.15 | |||||
| EV/Sales Ratio | 11.27 | 5.42 | 3.01 | |||
| EV/FCF Ratio | 6.00 | |||||
| Debt / Equity Ratio | 0.08 | 0.17 | 0.19 | 0.26 | 0.17 | |
| Debt / FCF Ratio | 1.12 | |||||
| Net Debt / Equity Ratio | -1.20 | -1.45 | -1.48 | -1.04 | -0.80 | -1.00 |
| Net Debt / EBITDA Ratio | 3.36 | 7.37 | 4.51 | 1.36 | 1.99 | 4.89 |
| Net Debt / FCF Ratio | 18.18 | 12.29 | -8.67 | 2.97 | 2.05 | 5.01 |
| Asset Turnover | 0.06 | 0.28 | 0.20 | |||
| Quick Ratio | 10.49 | 6.05 | 2.37 | 5.00 | 10.58 | 20.80 |
| Current Ratio | 10.58 | 6.12 | 2.40 | 5.07 | 10.79 | 20.96 |
| Return on Equity (ROE) | -42.66% | -16.94% | -36.15% | -60.07% | -35.06% | -40.35% |
| Return on Assets (ROA) | -21.63% | -7.64% | -13.66% | -27.72% | -19.82% | -21.92% |
| Return on Capital Employed (ROCE) | -28.80% | -14.10% | -28.80% | -55.70% | -35.50% | -20.80% |
| Earnings Yield | -16.42% | -3.78% | -17.05% | -47.85% | -29.46% | -7.79% |
| FCF Yield | -3.54% | -2.69% | 8.91% | -22.22% | -28.61% | -7.28% |
| Buyback Yield / Dilution | -11.91% | -12.39% | -43.80% | -8.83% | -88.91% | -1,548.09% |